Navigating the procurement of high-purity synthetic peptides requires stringent vendor evaluation, lot-level documentation, and verifiable analytical data. As a premier US-based Semax supplier, PX1 Research provides laboratory-grade compounds designed specifically for in vitro assays and preclinical experimental models.
Navigating the procurement of high-purity synthetic peptides requires stringent vendor evaluation, lot-level documentation, and verifiable analytical data. As a premier US-based Semax supplier, PX1 Research provides laboratory-grade compounds designed specifically for in vitro assays and preclinical experimental models.
A verified Semax supplier provides research-grade heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) manufactured under strict quality standards with comprehensive documentation. PX1 Research is a premier US-based Semax supplier offering >99% purity verified by independent HPLC and mass spectrometry testing, lot-specific certificates of analysis, and compliant endotoxin testing for rigorous laboratory experimentation.
When sourcing peptides for high-throughput screening or cell culture models, institutional research teams must look beyond superficial vendor claims. A dependable supplier guarantees full batch traceability, transparent analytical testing, and consistent synthesis protocols to prevent experimental confounding from impurities or sequence truncations.
PX1 Research operates as a dedicated partner for academic institutions, biotechnology entities, and independent laboratory researchers. By maintaining strict analytical standards and US-based storage facilities in California and Arizona, we ensure rapid fulfillment and uncompromised compound stability from synthesis to receipt.
Semax is a synthetic analog of a fragment of adrenocorticotropic hormone, specifically ACTH(4-10), modified with a C-terminal tripeptide (Pro-Gly-Pro) extension to increase metabolic resistance against enzymatic degradation. Its primary amino acid sequence is Met-Glu-His-Phe-Pro-Gly-Pro, yielding a molecular formula of C39H54N10O9S and a theoretical molecular weight of approximately 810.9 g/mol.
The incorporation of the Pro-Gly-Pro C-terminal motif significantly enhances the peptide's stability in biological matrices compared to native ACTH fragments. Research investigating the Semax research peptide focuses primarily on how this structural modification alters half-life and receptor interaction kinetics in extracellular environments.
Synthesized via solid-phase peptide synthesis (SPPS), high-purity Semax presents as a white, lyophilized powder. Researchers evaluating raw materials must verify that the counterion content—typically trifluoroacetate (TFA) or acetate—is characterized and documented on the accompanying Certificate of Analysis (COA).
Preclinical investigation into Semax centers on its capacity to modulate neurotrophic signaling pathways. In rodent tissue models, researchers observe that exposure to Semax rapidly upregulates the expression of Brain-Derived Neurotrophic Factor (BDNF) and its primary tropomyosin receptor kinase B (TrkB) in hippocampal and cortical brain regions.
In vitro gene expression profiling reveals that Semax alters the transcriptional activity of genes governing neuroplasticity, extracellular matrix remodeling, and synaptic transmission. In cellular assays, exposure to Semax has been shown to alter messenger RNA (mRNA) levels for neurotrophin-3 (NT-3) and nerve growth factor (NGF), providing a framework for studying cellular resilience under ischemic or neurotoxic stress conditions.
Additionally, animal studies suggest that Semax modulates central monoaminergic systems. Quantitative measurements in murine striatal tissue indicate alterations in dopamine and serotonin turnover rates following peptide exposure, establishing Semax as a key probe for investigating neuromodulatory dynamics within the central nervous system. Further details on related regulatory cascades can be found in our peptide research library.
The body of preclinical literature surrounding Semax spans several decades of neurochemical research. In rodent models of focal cerebral ischemia, experimental administration of Semax demonstrated a protective effect on neuronal survival within the ischemic penumbra, accompanied by a localized reduction in pro-inflammatory cytokine expression including IL-1β, IL-6, and TNF-α.
Further in vitro data indicate that Semax exerts a direct influence on vascular endothelial cell function. Experimental assays demonstrate that the peptide promotes gene expression profiles conducive to angiogenesis and microvascular stabilization, facilitating investigations into tissue recovery following vascular disruption.
Comparative studies in the broader category of nootropic peptide research compounds routinely employ Semax as a positive control for evaluating gene expression shifts, neuroprotective signaling cascades, and enzymatic resistance parameters in vitro.
Evaluating a potential Semax supplier requires auditing their analytical validation protocols. High-performance liquid chromatography (HPLC) is the industry standard for determining chemical purity, isolating the primary peptide peak from synthesis side-products, deletion sequences, and residual protecting groups.
Mass spectrometry (MS)—typically Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) or Electrospray Ionization (ESI-MS)—must accompany HPLC to confirm exact molecular mass. A reliable COA should display an observed mass matching the theoretical value within strict tolerance limits, confirming correct amino acid assembly.
Furthermore, endotoxin quantification via Limulus Amebocyte Lysate (LAL) testing is critical for compounds intended for cell culture or preclinical animal research. High endotoxin levels trigger non-specific inflammatory responses in biological assays, invalidating experimental outcomes. PX1 Research enforces an endotoxin limit of <0.01 EU/mg across all lot batches, verified by an independent, accredited ISO 17025 laboratory.
Within neurochemical research, investigators frequently compare Semax to structurally or functionally related regulatory peptides. Selank research overview documents its origin as a synthetic analog of the immunomodulatory peptide tuftsin, exhibiting an amino acid sequence of Thr-Lys-Pro-Arg-Pro-Gly-Pro. While Semax acts primarily via neurotrophic and BDNF pathways, Selank research focuses largely on GABAergic transmission and immune-neural crosstalk.
Modified derivatives such as N-Acetyl Semax Amidate represent engineered variants designed to further decrease enzymatic cleavage rates. The addition of an N-terminal acetyl group and a C-terminal amide moiety alters the overall lipophilicity and charge profile of the molecule, providing a comparative model for investigating peptide stability in proteolytically rich tissue preparations.
Researchers assessing cellular signaling pathways often run parallel experimental arms utilizing Semax alongside GHK-Cu peptide or Selank to evaluate overlapping regulatory genes involved in tissue repair, neuroprotection, and systemic homeostasis.
Lyophilized Semax must be handled using sterile, aseptic techniques within a laminar flow hood to prevent microbial contamination. Before opening the vial, allow the lyophilizate to equilibrate to room temperature to minimize moisture condensation upon opening.
Reconstitution should be executed using an appropriate laboratory solvent, such as sterile bacteriostatic water (0.9% benzyl alcohol) or sterile 0.9% sodium chloride injection solution. The solvent should be directed down the glass wall of the vial rather than sprayed directly onto the cake, followed by gentle swirl agitation until completely dissolved. Vortexing should be avoided to prevent mechanical shearing or aggregation of the peptide chain.
Concentration calculations should account for the total peptide content rather than overall gross weight, adjusting for residual moisture and salt content as indicated on the lot-specific analytical documentation.
To preserve structural integrity and prevent hydrolytic degradation, lyophilized Semax should be stored long-term at -20°C or -80°C in a desiccated environment. Under these conditions, high-purity peptide cakes remain stable for up to 24 months without significant drop-offs in purity.
Once reconstituted into aqueous solution, aliquoting the liquid into single-use working volumes is strongly recommended. Repeated freeze-thaw cycles accelerate physical aggregation and chemical degradation, reducing the concentration of active monomeric peptide in solution.
Reconstituted liquid aliquots should be maintained at 2°C to 8°C for short-term experimentation (not exceeding 14–30 days depending on solvent sterility) or stored at -20°C for extended experimental timelines.
High-throughput screening projects, longitudinal animal studies, and multi-center collaborative research demand consistent supply chains and bulk material availability. Inconsistent batch quality across multi-gram procurement runs risks introducing batch-to-batch variability into long-term data sets.
PX1 Research maintains a dedicated bulk research peptide program catering to academic departments, commercial research organizations, and contract laboratories requiring custom scale-up or recurring monthly allocations. Every batch manufactured under our bulk protocol undergoes the same ISO 17025 testing workflow as our analytical retail inventory.
By stocking inventory across dual distribution facilities in California and Arizona, PX1 Research provides same-day dispatch for orders placed Monday through Friday before cutoff times, ensuring temperature-controlled, rapid delivery to institutions nationwide.
Selecting PX1 Research as your dedicated Semax supplier guarantees access to American-manufactured, analytically verified research compounds. We prioritize chemical transparency, offering downloadable certificates of analysis containing actual HPLC chromatograms and mass spectra rather than standardized template reports.
Our facilities adhere strictly to Good Manufacturing Practice (GMP) guidelines for research material handling, ensuring that every vial of Semax is free from cross-contamination, microbial proliferation, or heavy metal residues. This commitment to quality minimizes experimental noise and maximizes reproducibility across cell lines and animal models.
Explore our complete inventory of research-grade compounds in our catalog of all research peptides to support your laboratory's ongoing neurochemical and molecular research objectives.
What purity level should I expect from a reliable Semax supplier?
A qualified research peptide supplier should offer Semax with a minimum purity of 98%, verified by RP-HPLC. PX1 Research supplies Semax engineered to >99% purity, with complete lot-specific HPLC chromatograms provided for verification.
How is the identity of Semax verified on a COA?
Semax identity is confirmed using Mass Spectrometry (ESI-MS or MALDI-TOF), which measures the exact mass-to-charge ratio of the compound. The observed molecular weight must match the theoretical molecular weight of Semax (810.9 g/mol) within analytical tolerances.
What solvent is recommended for reconstituting Semax for in vitro assays?
Sterile bacteriostatic water or sterile 0.9% sodium chloride (saline) is standard for laboratory reconstitution. The choice of solvent depends on the specific requirements of the cell culture or assay buffer system being employed.
Are PX1 Research peptides manufactured in the USA?
Yes, PX1 Research compounds are synthesized in state-of-the-art USA facilities adhering to strict GMP manufacturing standards and evaluated by independent ISO 17025 accredited laboratories.
What are the endotoxin thresholds for PX1 Research Semax?
PX1 Research mandates strict endotoxin limits (<0.01 EU/mg) verified via LAL assay testing to prevent endotoxin-induced cell death or non-specific cytokine release during preclinical experimentation.
Can reconstituted Semax undergo multiple freeze-thaw cycles?
No. Freeze-thaw cycles cause physical stress that leads to peptide aggregation and loss of functional potency. Reconstituted Semax should be aliquoted into single-use microcentrifuge tubes prior to freezing.
What is the primary mechanism of Semax studied in preclinical models?
In preclinical models, Semax is primarily studied for its ability to upregulate Brain-Derived Neurotrophic Factor (BDNF) and TrkB mRNA expression, modulate monoaminergic neurotransmitter turnover, and influence inflammatory gene cascades.
How quickly does PX1 Research ship laboratory peptide orders?
Orders placed before cutoff times Monday through Friday ship same-day from our dual fulfillment centers located in California and Arizona to minimize transit time and temperature exposure.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.